We are live on
!
Find out more
GA
GuoLine Advisory Portfolio holdings
AUM
$1.07B
1-Year Est. Return
26.27%
This Fund
S&P 500
This Quarter
Est. Return
+7.35%
1 Year Est. Return
+26.27%
3 Year Est. Return
+81.88%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$937M
AUM Growth
+$117M
(+14%)
Cap. Flow
+$59.8M
Cap. Flow
% of AUM
6.38%
Top 10 Holdings %
Top 10 Hldgs %
62.91%
Holding
20
New
1
Increased
3
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$38.6M |
| 2 |
Salesforce
CRM
|
+$20.4M |
| 3 |
ServiceNow
NOW
|
+$7.14M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$5.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.58% |
| 2 | Healthcare | 24.33% |
| 3 | Financials | 19.12% |
| 4 | Communication Services | 9.64% |
| 5 | Consumer Discretionary | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.45T
| $108M | 11.49% |
240,900
| – | – |
|
2
Alphabet (Google) Class A
GOOGL
$4.36T
| $90.3M | 9.64% |
496,000
| – | – |
|
3
Apple
AAPL
$4.54T
| $78.3M | 8.35% |
371,700
| – | – |
|
4
Mastercard
MA
$502B
| $49.9M | 5.32% |
113,000
| – | – |
|
5
Thermo Fisher Scientific
TMO
$213B
| $49.8M | 5.31% |
90,000
| – | – |
|
6
Visa
V
$684B
| $47.2M | 5.04% |
180,000
| – | – |
|
7
KLA
KLAC
$239B
| $43.3M | 4.62% |
525,000
| – | – |
|
8
Arthur J. Gallagher & Co
AJG
$64.1B
| $41.4M | 4.42% |
159,600
| – | – |
|
|
NVO
9
Novo Nordisk
NVO
$208B
| $41.1M | 4.38% |
287,600
| – | – |
|
10
S&P Global
SPGI
$121B
| $40.8M | 4.35% |
91,400
| – | – |
|
|
11
Amazon
AMZN
$2.92T
| $40.6M | 4.33% |
+210,050
| New | +$38.6M |
|
|
12
ServiceNow
NOW
$115B
| $40M | 4.27% |
254,250
+48,650
| +24% | +$7.14M |
|
13
Vertex Pharmaceuticals
VRTX
$121B
| $37.4M | 3.99% |
79,700
| – | – |
|
14
GE HealthCare
GEHC
$30.7B
| $35.9M | 3.83% |
461,000
| – | – |
|
|
15
Palo Alto Networks
PANW
$270B
| $34.7M | 3.7% |
204,800
-82,800
| -29% | -$12.4M |
|
|
16
Regeneron Pharmaceuticals
REGN
$78.5B
| $33.7M | 3.6% |
32,060
+6,160
| +24% | +$5.97M |
|
17
Adobe
ADBE
$99.5B
| $33.3M | 3.56% |
60,020
| – | – |
|
18
CrowdStrike
CRWD
$194B
| $31.5M | 3.36% |
328,400
| – | – |
|
|
19
Salesforce
CRM
$151B
| $30.3M | 3.23% |
117,890
+76,390
| +184% | +$20.4M |
|
20
Zoetis
ZTS
$32.4B
| $30.2M | 3.23% |
174,400
| – | – |
|
Similar funds
SCM
PP
DCP
ZIG
EC
FNT
TAM
EG
GuoLine Advisory's Q2 2024 Portfolio in Review
As of Q2 2024, GuoLine Advisory held 20 positions worth $937M, up 14% from $820M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
GuoLine Advisory deployed $59.8M of net new capital in Q2 2024, opening 1 new position and adding to 3 existing holdings. Its largest new stake was Amazon: 210,050 shares worth $40.6M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 42% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Palo Alto Networks, an estimated $12.4M trimmed.
- GuoLine Advisory's largest Q2 2024 buy was Amazon: 210,050 shares worth $40.6M.
- GuoLine Advisory added most to Salesforce in Q2 2024, an estimated $20.4M increase.
- GuoLine Advisory's biggest Q2 2024 reduction was Palo Alto Networks, cutting an estimated $12.4M.
- GuoLine Advisory's ten largest holdings make up 63% of its $937M portfolio in Q2 2024.
- GuoLine Advisory opened 1 new position and closed 0 in Q2 2024.
- GuoLine Advisory's portfolio value rose 14% quarter-over-quarter to $937M.
Based on GuoLine Advisory's 13F filing for Q2 2024, filed 12 Jul 2024.